Program
VIRTUAL PLATFORM ACCESS
Click Here to access the CLM Virtual Platform.
Reach out to clm_reg@mci-group.com for any assistance with logging in.
*Subject to Change
Times are in Eastern Daylight Time (EDT)
Tuesday, May 4, 2021
-
09:30
10:00
BREAK | VISIT THE VIRTUAL EXHIBITION
-
10:00
16:15
North American Viral Hepatitis Elimination Summit
-
10:00
11:00
Concurrent Sessions
CLM Symposium 1 – Basic Science and Translational Research - Novel Approaches to Targeting Chronic Liver Disease and Liver Injury
Moderator: Chris Rose
10:00 - 10:15 | Clinical Evidence on Targeting the Gut Microbiome in Chronic Liver Disease | Johane Allard, Medical Expert, Scholar
10:15 - 10:30 | Hepatic stellate in liver disease and cancer | Robert Schwabe, Medical Expert, Scholar
10:30 - 10:45 | Single Domain Nanobodies Targeting Viral Infection | Trushar Patel, Medical Expert
10:45 - 11:00 | Discussion
CLM Symposium 2 – Special Topics in Hepatology
Moderator: Kelly Burak
10:00 - 10:15 | Approaches to Complications in PSC Management | Angela Cheung, Medical Expert
10:15 - 10:30 | HCC Management in 2021 (Include Post-Transplant Surveillance for HCC) | Alex Aspinall, Medical Expert
10:30 - 10:45 | Acute-On – Chronic Liver Failure in the Era of COVID-19 | Constantine Karvellas, Medical Expert, Health Advocate, Leader
10:45 - 11:00 | Discussion
-
11:00
11:50
How COVID has Impacted Viral Hepatitis and the Elimination Agenda
This session was co-developed with Gilead and was planned to achieve scientific integrity, objectivity and balance.
Moderator: John Ward
11:00 - 11:20 | Effects of COVID-19 on the Cascade of Care | Naveed Janjua, Health Advocate, Leader
11:20 - 11:40 | Lessons Learned from COVID that Could Enhance Viral Hepatitis Elimination | Betsy Verna, Communicator, Leader, Health Advocate
11:40 - 11:50 | Q&A
-
11:00
11:30
HDV Cure
Moderator: Scott Fung
11:00 - 11:20 | HDV Cure: How close are we and what tools do we need? | Jeffrey Glenn, Medical Expert, Scholar
11:20 - 11:30 | Discussion
-
11:30
13:00
Strategies for HBV Cure
Moderator: Timothy Block
11:30 - 11:50 | The Antiviral Approach | Anna Lok, Medical Expert, Communicator
11:50 - 12:10 | The Immunological Approach | Barbara Rehermann, Medical Expert, Communicator
12:10 - 12:30 | HCC After Cure of HCV or Suppression of HBV | Emmanuel Thomas, Medical Expert, Scholar
12:30 - 13:00 | Panel Discussion
-
11:50
13:00
Opportunities from COVID to Enhance Elimination
Moderator: Jordan Feld, Health Advocate, Medical Expert
11:50 - 12:10 | Leveraging COVID Testing to Enhance HBV and HCV Screening: Opportunities for Progress Toward Elimination | Mel Krajden, Health Advocate, Medical Expert, Leader
12:10 - 12:30 | COVID-19 in Patients with Liver Disease and Management of Viral Hepatitis in the COVID Era | Oren Fix, Leader, Health Advocate, Medical Expert
12:30 - 13:00 | Panel Discussion Focused on Catch-up from COVID to Get Back on Track | Norah Terrault
-
13:00
13:30
BREAK | A CASE BASED ROUND TABLE DISCUSSION
The MDT Approach to HCC Management | Howie Lim & Dave Liu
This is an unaccredited other learning activity, with content developed by the speaker, and was made possible with the support of Eisai.
-
13:00
13:30
BREAK | VISIT THE VIRTUAL EXHIBITION
-
13:30
14:30
Oral Presentations ‑ Panel 2
Moderator: Joyce Wilson
13:30 - 13:40 | Cd8+ T Cell Hyperfunction In A Murine Model Of Liver Fibrosis | Jood Madani
13:40 - 13:50 | Enriched Plasma Cell Transcriptomic Signatures And Humoral Responses During Hcv Reinfection And Clearance | Sabrina Mazouz
13:50 - 14:00 | The Impact Of Small Rna Binding On Hepatitis C Virus Replication Via Structural Changes Within The 5’ Untranslated Region | Michael Palmer
14:00 - 14:10 | Higher Seroprotection Rates (Sprs) And Higher Anti-Hbs Concentrations In Adults Age 18+ Achieved With 3-Antigen Hepatitis B Vaccine (3A-Hbv) Compared To 1-Antigen Hepatitis B Vaccine (1A-Hbv): Results From The Pivotal, Double-Blind, Randomized Phase 3 Study (Protect) | Francisco Diaz-Mitoma
14:10 - 14:30 | Q&A
-
13:30
14:30
CAHN Session
Nurse-Led Models of Care
Moderator: Leo Yamamoto
13:30 - 13:50 | HCV Micro Elimination at the Calgary Drop-In Center: an interdisciplinary approach to screening and treatment | Kate Newcombe
13:50 - 14:10 | Culturally Relevant Perspectives Informing Indigenous Liver Health Awareness | Kate Dunn
14:10 - 14:30 | Cirrhosis Care Alberta - a QI project | Michelle Carbonneau
-
14:30
15:30
CAHN Session
Case Studies In Liver Disease
Moderator: Leeya Brind’Amour
14:30 - 14:45 | HCV treatment dilemma | Liza Abraham
14:45 - 15:00 | Serious Illness Conversations in Advanced Liver Disease | Jacqui Pinto
15:00 - 15:15 | HCV reinfection | Pam Ford
15:15 - 15:30 | Q&A
-
14:30
15:00
CanHepC Awards Ceremony
Presented by: Norma Choucha, Chris Richardson, Naglaa Shoukry, & CanHepC trainees
-
15:00
15:30
Elimination Summit Next Steps and Closing Remarks
15:00 - 15:15 | An elimination call from Community - Elimination Progress Report by Action Hepatitis Canada | Sofia Bartlett & Jennifer van Gennip
15:15 - 15:20 | From Blueprint to Roadmap | Jordan Feld
15:20 - 15:25 | Hepatitis Elimination Profiles US & Canada & Closing Remarks | John Ward
15:25 - 15:30 | I Never Had No Nobel Dreams | Harvey Alter (Poem, World Premiere)
-
15:30
17:00
-
15:30
16:30
-
15:30
16:30
VISIT THE VIRTUAL Exhibition
-
15:30
16:15
Poster Tours
Poster Tour 3
Poster Tour 4
